CochLear (OTCMKTS:CHEOY) Lowered to “Strong Sell” Rating by Zacks Research

Zacks Research downgraded shares of CochLear (OTCMKTS:CHEOY) from a hold rating to a strong sell rating in a report published on Monday morning,Zacks.com reports.

Separately, UBS Group lowered CochLear from a “strong-buy” rating to a “hold” rating in a research report on Thursday, April 23rd. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, CochLear currently has an average rating of “Hold”.

CochLear Trading Up 3.0%

OTCMKTS CHEOY opened at $37.83 on Monday. The business’s 50-day moving average price is $41.45 and its two-hundred day moving average price is $66.16. CochLear has a 12 month low of $31.82 and a 12 month high of $105.60.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.